| Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors. | |
| | |
MedLine Citation:
|
PMID: 21876172 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The rationale for the pursuit of bacterial type 2 fatty acid synthesis (FASII) as a target for antibacterial drug discovery in Gram-positive organisms is being debated vigorously based on their ability to incorporate extracellular fatty acids. The regulation of FASII by extracellular fatty acids was examined in Staphylococcus aureus and Streptococcus pneumoniae, representing two important groups of pathogens. Both bacteria use the same enzymatic tool kit for the conversion of extracellular fatty acids to acyl-acyl carrier protein, elongation, and incorporation into phospholipids. Exogenous fatty acids completely replace the endogenous fatty acids in S. pneumoniae but support only 50% of phospholipid synthesis in S. aureus. Fatty acids overcame FASII inhibition in S. pneumoniae but not in S. aureus. Extracellular fatty acids strongly suppress malonyl-CoA levels in S. pneumoniae but not in S. aureus, showing a feedback regulatory system in S. pneumoniae that is absent in S. aureus. Fatty acids overcame either a biochemical or a genetic block at acetyl-CoA carboxylase (ACC) in S. aureus, confirming that regulation at the ACC step is the key difference between these two species. Bacteria that possess a stringent biochemical feedback inhibition of ACC and malonyl-CoA formation triggered by environmental fatty acids are able to circumvent FASII inhibition. However, if exogenous fatty acids do not suppress malonyl-CoA formation, FASII inhibitors remain effective in the presence of fatty acid supplements. |
| | |
Authors:
|
Joshua B Parsons; Matthew W Frank; Chitra Subramanian; Panatda Saenkham; Charles O Rock |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2011-08-29 |
Journal Detail:
|
Title: Proceedings of the National Academy of Sciences of the United States of America Volume: 108 ISSN: 1091-6490 ISO Abbreviation: Proc. Natl. Acad. Sci. U.S.A. Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-09-14 Completed Date: 2011-11-09 Revised Date: 2012-03-13 |
Medline Journal Info:
|
Nlm Unique ID: 7505876 Medline TA: Proc Natl Acad Sci U S A Country: United States |
Other Details:
|
Languages: eng Pagination: 15378-83 Citation Subset: IM |
Affiliation:
|
Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN 38105, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetyl-CoA Carboxylase
/
metabolism Adaptation, Physiological / drug effects Benzofurans / pharmacology Fatty Acid Synthesis Inhibitors / pharmacology* Fatty Acid Synthetase Complex / metabolism Fatty Acids / metabolism, pharmacology Microbial Sensitivity Tests Mutation / genetics Phenotype Pyrones / pharmacology Staphylococcus aureus / drug effects*, enzymology, metabolism* Streptococcus pneumoniae / drug effects*, enzymology, metabolism* |
| Grant Support | |
ID/Acronym/Agency:
|
CA21765/CA/NCI NIH HHS; GM034496/GM/NIGMS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/API 1252; 0/Benzofurans; 0/Fatty Acid Synthesis Inhibitors; 0/Fatty Acids; 0/Pyrones; EC 6.-/Fatty Acid Synthetase Complex; EC 6.4.1.2/Acetyl-CoA Carboxylase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Connective tissue growth factor acts within both endothelial cells and beta cells to promote prolife...
Next Document: Differentiation-dependent functional and epigenetic landscapes for cytokine genes in virus-specific ...